SCHEMBL4757381

SCHEMBL4757381

Cc1ccc(C(=O)Nc2ncc(NS(C)(=O)=O)s2)c(O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 4/20 0.60
KDR P35968 1/20 0.43
PLG P00747 3/20 0.42
KLK1 P06870 2/20 0.42
KLK6 Q92876 2/20 0.42
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
PLAU P00749 1/20 0.41
PLAT P00750 1/20 0.41
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 1/20 0.40
POLQ O75417 2/20 0.39
NPC1 O15118 4/20 0.39
LMNA P02545 2/20 0.39
RAB9A P51151 3/20 0.39
MITF O75030 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114640 0.84 STAT3 (0.43) STAT3POLQMEN1KMT2A
SCHEMBL4757379 0.84 STAT3 (0.56) STAT3ALDH1A1NPC1LMNARAB9A
SCHEMBL4755924 0.83 STAT3 (0.63) STAT3KDRPLGKLK1KLK6
SCHEMBL4757387 0.81 KCNMA1 (0.54) STAT3KDR
SCHEMBL23026965 0.79 STAT3 (0.67) STAT3KDRPLGKLK1KLK6
SCHEMBL30945145 0.79 STAT3 (0.67) STAT3KDRPLGKLK1KLK6
SCHEMBL4756532 0.79 STAT3 (0.60) STAT3KDRPLGKLK1KLK6
SCHEMBL4757380 0.76 STAT3 (0.46) STAT3ALDH1A1POLQNPC1LMNA
SCHEMBL5795075 0.75 STAT3 (1.00) STAT3ALDH1A1NPC1LMNARAB9A
SCHEMBL29908284 0.75 STAT3 (1.00) STAT3ALDH1A1NPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885KDR 4456/4885PLG 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.